Debunking Common Fitness Misconceptions | Thomas DeLauer

Dr. Singh's clinical guidance: use inflammation markers (CRP, IL-6) as the first outcome signal. If those decrease within 6–8 weeks, the pathway is working. Long-term the best proxy is endurance performance — VO2 max-adjacent metrics in trials showed significant improvements in middle-aged and older populations. The 89-year-old participant in one blinded trial correctly identified herself as being in the active arm because she was gardening more — consistent with the improved muscle function seen in formal endpoints.

DeLauer points out that taurine sits at a crossroads of fat oxidation (via CPT-1 activity), antioxidant protection, and apparent metabolic demand signaling in muscle. Muscle biopsies from exhausted athletes show dramatically elevated taurine concentrations, suggesting the muscle is either pulling it in as an antioxidant or using it in ways not yet fully characterized. The fact that a 1 g dose and a 6 g dose produce equivalent outcomes suggests a saturation point rather than a dose-dependent relationship.

DeLauer spent years avoiding beta-alanine because he believed the burn was the beneficial signal (lactate-driven adaptation). He eventually reconsidered after reviewing the literature: buffering hydrogen ions does not suppress lactate signaling, because the H+ and lactate rise together but are not the same compound. The 2,000-meter rowing study is his reference anchor: 6.4 seconds is not by chance when everyone in the trial improved, and the 800m runner equivalent would feel that margin as a decisive competitive gap.

DeLauer's observation: when protein intake drops even slightly, cravings for carbohydrates and fat return — suggesting protein satiety effect is not just caloric but hormonal. He reverse-engineers lean individuals' diets and finds high protein consistently. He also recommends pairing high protein with 35–40 g daily fiber (higher than the recommended 25 g), particularly from soluble sources like flax and chia, noting both act through overlapping GLP-1 receptor mechanisms to suppress appetite.

DeLauer spent years in a ketogenic and low-carb content world, but describes his current framework as having evolved: the highest-leverage intervention is movement volume throughout the day, followed by protein quantity, followed by training as a hormonal and signaling catalyst. His personal NEAT strategy: if he is sitting on the couch and there are dishes to be done, he treats doing them as an intentional NEAT decision. Those little things stack up.

DeLauer uses BFR specifically on filming days because lactate-driven BDNF makes him feel cognitively sharp without the physical fatigue that would impair a long filming session. He uses 10–15 lb dumbbells for curls (versus his normal 50+ lb), does high reps, and removes the cuffs after 20 minutes even if he is not done. Lane Norton was an early proponent; physical therapists have adopted BFR for prehab and rehab with strong outcomes literature.

DeLauer's nuance on sauna before versus after exercise: before a run, it loosens him up and the mechanistic case is arguable (mobilized lipids, raised HSP before thermal exposure of exercise). After exercise, the GH stimulus and satellite cell signaling rationale is stronger. The key finding from a hypertrophy standpoint: heat shock proteins appear to facilitate satellite cell fusion to muscle fibers, which is one pathway of new myonuclei addition — independent of mechanical overload. Some newer literature also suggests augmented muscle protein synthesis from post-exercise sauna exposure.

Dr. Honog Singh's team at Amazentis spent 15 years taking Urolithin A from worm studies through multiple randomized controlled trials in humans. The molecule is measured in dried blood spot tests and circulates detectably only in 'producers.' The therapeutic threshold appears to be approximately 100 ng/mL. Singh divides the population into three tiers: 60% non-producers (no detectable Urolithin A even with healthy diet), 20–30% who make low levels with good diet (probably sub-therapeutic), and 10% 'super producers' who may be naturally protected from sarcopenia.

Singh's clinical biomarker guidance: the first signal that mitophagy is working is a reduction in inflammatory markers — specifically C-reactive protein and IL-6, which is directly linked to muscle strength. These blunt within 1–2 months across every trial. Post-mitophagy biogenesis is measured by improvement in endurance and VO2 max parameters. In Olympian-level athletes, Urolithin A provided two benefits: faster clearance of overtraining-induced muscle damage (blunting creatine kinase and lactate elevations) and suppression of systemic inflammation (high CRP is endemic in elite athletes). The key practical point: once you take it continuously, the acute mitophagy phase ends and you shift to a predominantly biogenesis effect — so it does not perpetually strip your mitochondria.

DeLauer's framing: taurine is unique because it acts as both an antioxidant and appears to accumulate specifically in exercised muscle during heavy training (based on muscle biopsy studies), suggesting an acute demand signal that dietary intake rarely keeps pace with. The pharmacokinetics are favorable for ad hoc use: peak plasma levels appear approximately 1 hour after ingestion and then decline over 6–7 hours — meaning you can take it before a specific session rather than loading chronically. DeLauer personally notes that a good 8–12 oz steak provides about 1 gram of taurine (raw), while the supplementation literature shows the 1–6 g range produces equivalent benefit, suggesting more is not better.

The BFR mechanism: occlusion cuffs block 40–60% of venous return while allowing arterial inflow. Metabolites including lactate pool in the trained limb. This amplified local lactate signal drives HIF-1alpha just as hypoxic high-intensity training would, but with a 10–20 lb dumbbell instead of a heavy barbell — making it safe for rehab, high-mileage running weeks, or older adults unable to tolerate heavy loads. Protocol: lighter weight, higher reps, maximum 20 minutes per limb per session, do not use arms and legs simultaneously, use properly calibrated cuffs (Smart Tools, Deli, BeStrong — not improvised tourniquet-style). DeLauer personally uses BFR 1–2 times per week on filming days to get the BDNF cognitive boost from lactate without CNS fatigue from heavy lifting.

DeLauer's practical nuance: he does cold plunge at night rather than in the morning because his morning cortisol is already very high (tested), and the adrenaline dump from a morning cold plunge crashes his energy mid-morning. Evening cold plunge (2–3 minutes) lowers core temperature, which increases melatonin and improves sleep. Theanine (found in green tea) is synergistic with caffeine because it is a vasodilator that counteracts caffeine vasoconstriction, allowing better lipid circulation and a more sustained effect without increasing tolerance.

DeLauer's personal experience: at 180 lbs, 1–3 g of beta-alanine provides his effective dose; at 220 lbs he needed more — suggesting body-weight scaling is relevant. He now observes that his time to exhaustion in the 12–20 rep range is significantly better with beta-alanine and that the effect persists for about 90 minutes before fading. His prior concern — that by buffering hydrogen ions you suppress the lactate signaling that drives adaptation — turned out to be unfounded based on his review of the literature on carnosine and HIF-1alpha.

DeLauer's personal protocol: sauna at 230 degrees F (his personal rigged maximum), 15–20 minute bouts, 3 times per week. He will sometimes sauna before a run because it loosens connective tissue and mildly activates adaptive mechanisms in advance, though the stronger recovery and GH rationale supports post-exercise sauna. He avoids sauna immediately after head injury because the increased intracranial pressure is contraindicated with brain inflammation. For listeners without access to high-heat saunas, he suggests 20 minutes at 190 degrees F 3 times per week as a well-supported protocol from the Finnish literature.